+

WO2002031160A3 - Regulation de l'enzyme de type a2 phospholipase humaine - Google Patents

Regulation de l'enzyme de type a2 phospholipase humaine Download PDF

Info

Publication number
WO2002031160A3
WO2002031160A3 PCT/EP2001/011640 EP0111640W WO0231160A3 WO 2002031160 A3 WO2002031160 A3 WO 2002031160A3 EP 0111640 W EP0111640 W EP 0111640W WO 0231160 A3 WO0231160 A3 WO 0231160A3
Authority
WO
WIPO (PCT)
Prior art keywords
enzyme
human phospholipase
regulation
reagents
phospholipase
Prior art date
Application number
PCT/EP2001/011640
Other languages
English (en)
Other versions
WO2002031160A2 (fr
Inventor
Zhimin Zhu
Original Assignee
Bayer Ag
Zhimin Zhu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Zhimin Zhu filed Critical Bayer Ag
Priority to AU2001295602A priority Critical patent/AU2001295602A1/en
Publication of WO2002031160A2 publication Critical patent/WO2002031160A2/fr
Publication of WO2002031160A3 publication Critical patent/WO2002031160A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des réactifs qui régulent l'enzyme de type A2 phospholipase humaine et des réactifs qui se lient aux produits génétiques de l'enzyme de type A2 phospholipase humaine peuvent jouer un rôle en empêchant, améliorant ou corrigeant des dysfonctionnements ou des maladies incluant de manière non exhaustive, l'asthme, les cancers, les inflammations, les troubles du SNC, les troubles cardiovasculaires, la bronchopneumopathie chronique obstructive, le diabète et l'obésité.
PCT/EP2001/011640 2000-10-10 2001-10-09 Regulation de l'enzyme de type a2 phospholipase humaine WO2002031160A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001295602A AU2001295602A1 (en) 2000-10-10 2001-10-09 Regulation of human phospholipase a2-like enzyme

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US23843200P 2000-10-10 2000-10-10
US60/238,432 2000-10-10
US25805300P 2000-12-27 2000-12-27
US60/258,053 2000-12-27
US31796401P 2001-09-10 2001-09-10
US60/317,964 2001-09-10

Publications (2)

Publication Number Publication Date
WO2002031160A2 WO2002031160A2 (fr) 2002-04-18
WO2002031160A3 true WO2002031160A3 (fr) 2003-10-09

Family

ID=27399096

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/011640 WO2002031160A2 (fr) 2000-10-10 2001-10-09 Regulation de l'enzyme de type a2 phospholipase humaine

Country Status (2)

Country Link
AU (1) AU2001295602A1 (fr)
WO (1) WO2002031160A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002224774A1 (en) * 2000-10-10 2002-04-22 Bayer Aktiengesellschaft Human phospholipase a2-like enzyme
WO2002063005A2 (fr) * 2001-02-06 2002-08-15 Incyte Genomics, Inc. Molecules associees a des lipides
FR2847267B1 (fr) * 2002-11-19 2006-07-28 Coletica Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2
EP3993871A1 (fr) * 2019-07-02 2022-05-11 Fundacion para la Investigacion Medica Aplicada Agents induisant la cpla2e et leurs utilisations

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 May 1999 (1999-05-01), XP002225010, retrieved from EBI Database accession no. O95712 *
DATABASE EMBL [online] Database accession no. Q9UKV7 *
SONG CHUANZHENG ET AL: "Molecular characterization of cytosolic phospholipase A2-beta.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 24, Q9ukv7, 11 June 1999 (1999-06-11), pages 17063 - 17067, XP002212884, ISSN: 0021-9258, Retrieved from the Internet <URL:EBI> *
TODD PICKARD R ET AL: "Molecular cloning of two new human paralogs of 85-KDa cytosolic phospholipase A2", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 274, no. 13, O95712, 26 March 1999 (1999-03-26), pages 8823 - 8831, XP002143988, ISSN: 0021-9258, Retrieved from the Internet <URL:EBI> *

Also Published As

Publication number Publication date
WO2002031160A2 (fr) 2002-04-18
AU2001295602A1 (en) 2002-04-22

Similar Documents

Publication Publication Date Title
WO2002002797A3 (fr) Regulation d&#39;enzyme du type 11 beta-hydroxysteroide deshydrogenase 1 humaine
WO2002036754A3 (fr) Regulation de la lipase acide lysosomale humaine
WO2002006453A3 (fr) Regulation de protease a serine humaine de type desc1
WO2002031160A3 (fr) Regulation de l&#39;enzyme de type a2 phospholipase humaine
WO2002031162A3 (fr) Regulation de l&#39;enzyme du type phospholipase a2 humaine
WO2002031125A3 (fr) Regulation de l&#39;enzyme semblable a phospholipase a2 humaine
WO2002072824A3 (fr) Regulation du canal potentiel humain du recepteur transitoire humain
WO2002042435A3 (fr) Regulation de la tyrosine phosphatase humaine
WO2002031161A3 (fr) Regulation de l&#39;enzyme humaine de type phospholipase
WO2002010403A3 (fr) Regulation d&#39;une enzyme humaine de type phospholipase c a phosphatidylinositol specifique
WO2002026996A3 (fr) Regulation d&#39;enzyme humaine de type phospholipase c specifique du phosphatidylinositol
WO2002020732A3 (fr) Régulation d&#39;enzyme humaine de type map kinase phosphatase
WO2004031375A3 (fr) Regulation de la pde1c humaine
WO2002020747A3 (fr) Regulation de l&#39;enzyme humaine du type tyrosine phosphatase
WO2003052088A3 (fr) Regulation de la sialyltransferase humaine
WO2002032938A3 (fr) Regulation de la proteine humaine de type pgc-1
WO2002055710A3 (fr) Regulation de l&#39;acide phosphatase pourpre humain
WO2002000704A3 (fr) Regulation d&#39;une enzyme du type phospholipase c humaine
WO2003072767A3 (fr) Regulation de la lipase humaine
WO2002000855A3 (fr) Regulation de l&#39;enzyme humaine synthase acide gras s-acyl de la famille des thioesterase
WO2002036731A3 (fr) Lipase acide lysosomiale de l&#39;homme
WO2002033056A3 (fr) Regulation de serine-threonine kinase humaine
WO2002092798A3 (fr) Regulation d&#39;une proteine humaine de type 2c de phosphatase acide phosphatidique
WO2002036613A3 (fr) Regulation de la proteine humaine de type &#39;patched&#39;
WO2002090543A3 (fr) Régulation de la protéine semblable à celle de type 2c de la phosphatase de l&#39;acide phosphatidique humain

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载